点击图片查看原图
L-Ascorbyl 6-palmitate
Vorinostat (SAHA, Zolinza, MK-0683)
Afatinib (BIBW2992),CAS:439081-18-2
MK-2206 dihydrochlor
LY294002,CAS:154447-
SP600125,CAS:129-56-
Vismodegib (GDC-0449
Linsitinib (OSI-906)
Gefitinib (Iressa, Z
产品描述及优势
• 273种激酶抑制剂的独特集合，可用于高通量筛选和高内涵筛选 • 通过前期临床研究和临床实验，生物活性和安全性得到验证 • 其中一些激酶抑制剂已得到FDA批准 • 作用于激酶，如RTKs, PI3K, Aurora激酶, CDK和MEK • 大部分为ATP竞争性抑制剂 • 结构多样，药效显著，可渗透细胞 • 具有充分详细的结构说明，IC50值，及客户反馈资料 • NMR和HPLC技术保证产品高纯度
产品详细信息
| 配制: | 273种激酶抑制剂预溶在DMSO溶液中 | ||||||
|---|---|---|---|---|---|---|---|
| 96-孔板: | 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode | ||||||
| 稳定性: |
| ||||||
| 发货: | 蓝冰物流 | ||||||
| 包装: | 惰性气体 |
| Product Details: | |||||||||||||
| Formulation | A collection of 273 kinase inhibitors supplied as lyophilized powder or pre-dissolved DMSO solutions | ||||||||||||
| Container (Optional) | A: Deep-well 96-well plate | ||||||||||||
| B: 96-well racks with TrakMate screwtop tubes & caps | |||||||||||||
| Stability | |||||||||||||
| 2 weeks | 4°C | in DMSO | |||||||||||||
| 3 months | ﹣20°C | in DMSO | |||||||||||||
| 6 months | ﹣80°C | in DMSO | |||||||||||||
| Shipping | Blue ice | ||||||||||||
| Packaged under inert gas | Yes | ||||||||||||
| Plate layout: L1200-01 | |||||||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
| a | Empty | Linifanib (ABT-869) | Cediranib (AZD2171) | Imatinib Mesylate | Rapamycin (Sirolimus) | Enzastaurin (LY317615) | SB 216763 | Linsitinib (OSI-906) | GDC-0879 | GSK690693 | AT9283 | Empty | |
| b | Empty | Axitinib | Dovitinib (TKI-258) | Lapatinib Ditosylate (Tykerb) | Sorafenib (Nexavar) | BMS-599626 (AC480) | SB 203580 | KU-55933 | LY294002 | JNJ-38877605 | Brivanib alaninate (BMS-582664) | Empty | |
| c | Empty | Saracatinib (AZD0530) | CI-1033 (Canertinib) | Motesanib Diphosphate (AMG-706) | Sunitinib Malate (Sutent) | Masitinib (AB1010) | SB 202190 | GSK1904529A | OSU-03012 | PD 0332991 (Palbociclib) HCl | AG-490 | Empty | |
| d | Empty | AZD6244 (Selumetinib) | CI-1040 (PD184352) | Nilotinib (AMN-107) | Tandutinib (MLN518) | GDC-0941 | MK-2206 2HCl | PF-04217903 | Danusertib (PHA-739358) | Triciribine (Triciribine phosphate) | SNS-032 (BMS-387032) | Empty | |
| e | Empty | BEZ235 (NVP-BEZ235) | Dasatinib (BMS-354825) | Pazopanib HCl | Temsirolimus (Torisel) | SB 431542 | PD153035 HCl | MLN8054 | TAE684 (NVP-TAE684) | XL147 | Barasertib (AZD1152-HQPA) | Empty | |
| f | Empty | BIBF1120 (Vargatef) | Deforolimus (Ridaforolimus) | PD0325901 | Vandetanib (Zactima) | Crizotinib (PF-02341066) | SU11274 | Vatalanib 2HCl (PTK787) | BI 2536 | XL-184 (Cabozantinib) | PLX-4720 | Empty | |
| g | Empty | Afatinib (BIBW2992) | Erlotinib HCl | Empty | VX-680 (MK-0457, Tozasertib) | PHA-665752 | Brivanib (BMS-540215) | U0126-EtOH | Foretinib (GSK1363089, XL880) | Everolimus (RAD001) | Roscovitine (Seliciclib, CYC202) | Empty | |
| h | Empty | Bosutinib (SKI-606) | Gefitinib (Iressa) | PI-103 | Y-27632 2HCl | ZSTK474 | NVP-ADW742 | ZM-447439 | SGX-523 | MLN8237 (Alisertib) | SNS-314 | Empty | |
| Plate layout: L1200-02 | |||||||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
| a | Empty | E7080 (Lenvatinib) | WZ8040 | AG-1024 | BX-912 | Pelitinib (EKB-569) | TSU-68 (SU6668) | LY2228820 | AZD7762 | PD318088 | Neratinib (HKI-272) | Empty | |
| b | Empty | CP-724714 | ENMD-2076 | Amuvatinib (MP-470) | AMG-208 | AS-605240 | AS703026 (pimasertib) | CCT129202 | R406 (free base) | KU-60019 | KW 2449 | Empty | |
| c | Empty | TGX-221 | PIK-90 | JNJ-7706621 | TG100-115 | Staurosporine | SB 525334 | XL765 | CP 673451 | BS-181 HCl | Empty | Empty | |
| d | Empty | WZ3146 | PIK-75 | PD173074 | GSK1059615 | Aurora A Inhibitor I | HMN-214 | AT7519 | AZD8055 | BIRB 796 (Doramapimod) | LY2784544 | Empty | |
| e | Empty | CYC116 | Tivozanib (AV-951) | WYE-354 | MGCD-265 | PHA-680632 | AEE788 (NVP-AEE788) | Quizartinib (AC220) | PHT-427 | Tie2 kinase inhibitor | BGJ398 (NVP-BGJ398) | Empty | |
| f | Empty | WZ4002 | YM201636 | Vemurafenib (PLX4032) | ON-01910 | Thiazovivin | PHA-793887 | Hesperadin | KRN 633 | TWS119 | AST-1306 | Empty | |
| g | Empty | PD98059 | OSI-930 | IC-87114 | Ki8751 | SP600125 | PIK-93 | BIX 02188 | AT7867 | BMS-265246 | AZD8931 | Empty | |
| h | Empty | Regorafenib (BAY 73-4506) | Ku-0063794 | BX-795 | Ruxolitinib (INCB018424) | Empty | Ponatinib (AP24534) | BIX 02189 | BMS 777607 | AZD8330 | GSK461364 | Empty | |
| Plate layout: L1200-03 | |||||||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
| a | Empty | R406 | Mubritinib (TAK 165) | BI6727 (Volasertib) | Phenformin HCl | PF-05212384 (PKI-587) | A-674563 | CHIR-124 | TAK-901 | Crenolanib (CP-868596) | CHIR-98014 | Empty | |
| b | Empty | Raf265 derivative | PP242 | Palomid 529 | TAK-733 | DCC-2036 (Rebastinib) | AS-252424 | NVP-BSK805 | AMG 900 | Empty | AZ628 | Empty | |
| c | Empty | BMS 794833 | Cyt387 | WP1130 | LDN193189 | CCT128930 | PF-00562271 | WAY-600 | ZM 336372 | TG101348 (SAR302503) | AMG458 | Empty | |
| d | Empty | NVP-BHG712 | SB590885 | BKM120 (NVP-BKM120) | AZD5438 | A66 | GSK1120212 (Trametinib) | TG101209 | PF-03814735 | PKI-402 | NVP-BGT226 | Empty | |
| e | Empty | OSI-420 | Apatinib (YN968D1) | CX-4945 (Silmitasertib) | PP-121 | NU7441 (KU-57788) | Flavopiridol HCl | GDC-0980 (RG7422) | PH-797804 | GSK1070916 | Milciclib (PHA-848125) | Empty | |
| f | Empty | R935788 (Fostamatinib disodium, R788 disodium) | CAL-101 (GS-1101) | Indirubin | OSI-027 | GSK2126458 | PCI-32765 (Ibrutinib) | A-769662 | Dacomitinib (PF299804,PF-00299804) | PHA-767491 | Arry-380 | Empty | |
| g | Empty | PIK-293 | PIK-294 | Quercetin (Sophoretin) | R788 (Fostamatinib) | WYE-125132 | AS-604850 | KX2-391 | AG-1478 (Tyrphostin AG-1478) | PF-04691502 | ARQ 197 (Tivantinib) | Empty | |
| h | Empty | AZ 960 | Telatinib (BAY 57-9352) | Imatinib (Gleevec) | LY2603618 (IC-83) | WYE-687 | CAY10505 | GSK1838705A | SB 415286 | CCT137690 | ARRY334543 | Empty | |
| Plate layout: L1200-04 | |||||||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
| a | Empty | Wortmannin | AZD2014 | Dabrafenib (GSK2118436) | TPCA-1 | WHI-P154 | Empty | Empty | Empty | Empty | Empty | Empty | |
| b | Empty | NVP-BVU972 | TAK-285 | GDC-0068 | Desmethyl Erlotinib (CP-473420) | TG 100713 | Empty | Empty | Empty | Empty | Empty | Empty | |
| c | Empty | CH5424802 | INCB28060 | INK 128 (MLN0128) | Torin 1 | Piceatannol | Empty | Empty | Empty | Empty | Empty | Empty | |
| d | Empty | 3-Methyladenine | Tofacitinib (CP-690550, Tasocitinib) | BYL719 | SAR131675 | Tofacitinib citrate (CP-690550 citrate) | Empty | Empty | Empty | Empty | Empty | Empty | |
| e | Empty | Dinaciclib (SCH727965) | Sotrastaurin (AEB071) | Tyrphostin AG 879 (AG 879) | Semaxanib (SU5416) | VX-702 | Empty | Empty | Empty | Empty | Empty | Empty | |
| f | Empty | Dovitinib Dilactic acid (TKI258 Dilactic acid) | WP1066 | Torin 2 | Baricitinib (LY3009104,incb28050) | Empty | Empty | Empty | Empty | Empty | Empty | Empty | |
| g | Empty | MK-5108 (VX-689) | AZD4547 | NVP-TAE226 | Golvatinib (E7050) | Empty | Empty | Empty | Empty | Empty | Empty | Empty | |
| h | Empty | MK-2461 | CEP33779 | Tideglusib | IMD 0354 | Empty | Empty | Empty | Empty | Empty | Empty | Empty | |
